ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Imaging and Image-directed Interventions
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1656244
CT-based Deep Learning for Preoperative Prediction of Pathological Grading of Renal Clear Cell Carcinoma
Provisionally accepted- Affiliated Hospital of Hebei University, Baoding, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To construct a noninvasive preoperative prediction model for WHO/ISUP grading of renal clear cell carcinoma (ccRCC) using deep learning combined with four-phase CT images, and to evaluate its efficacy.Methods: A retrospective study was conducted on 158 ccRCC patients (124 low-grade, 34 high-grade) from the Affiliated Hospital of Hebei University (January 2022-June 2024). Patients were randomly divided into training, validation, and test sets at an 8:1:1 ratio. Four-phase CT images were preprocessed (rectangular box annotation of tumor region of interest [ROI], image resizing to 224×224 pixels). The ResNet34 model was first built to predict ccRCC grading, with performance evaluated by accuracy (ACC) and area under the receiver operating characteristic curve (AUC). The model was then optimized by integrating the SENet attention mechanism (forming the SE-ResNet34 model), and performance before and after optimization was compared.Results: ResNet34 models based on corticomedullary, parenchymal, and excretory phase images achieved ACC >0.8, with the parenchymal phase model showing the best performance (ACC=0.867, low-grade AUC=0.857, high-grade AUC=0.853). After adding the SENet attention mechanism, the SE-ResNet34 model exhibited improved performance: ACC increased to 0.878, low-grade AUC to 0.929, and high-grade AUC to 0.927.Conclusion: The SE-ResNet34 model based on parenchymal phase CT images has excellent ability to differentiate WHO/ISUP grades of ccRCC, providing an effective noninvasive auxiliary tool for preoperative pathological grading prediction in clinical practice. However, the model’s robustness and multi-center applicability need further validation before clinical use.”
Keywords: artificial intelligence, deep learning, Clear cell renal cell carcinoma, Pathological grading, Preoperative prediction
Received: 01 Jul 2025; Accepted: 30 Sep 2025.
Copyright: © 2025 Yang, Cui, Ma, Liu and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Wenzeng Yang, iqafjg@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.